Updated Story President Donald Trump has decided to withdraw a proposed rule to eliminate rebates in Medicare Part D and Medicaid managed care because of concerns the rule would raise premiums for Part D beneficiaries, an administration official told Inside Drug Pricing . The retreat is a blow to both HHS Secretary Alex Azar’s agenda and drug makers, who would likely have profited from the proposed rule. White House Domestic Policy Council head and fiscal conservative Joe...